Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors
about
A Central Role for STAT3 in Gammaherpesvirus-Life Cycle and -DiseasesKeeping it quiet: chromatin control of gammaherpesvirus latencyIdentification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial MalignanciesTracking expression and subcellular localization of RNA and protein species using high-throughput single cell imaging flow cytometry.Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acidsIdentification of a new class of small molecules that efficiently reactivate latent Epstein-Barr Virus.The ZIIR element of the Epstein-Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latencyCellular STAT3 functions via PCBP2 to restrain Epstein-Barr Virus lytic activation in B lymphocytes.Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.Human Cytomegalovirus Immediate-Early 1 Protein Rewires Upstream STAT3 to Downstream STAT1 Signaling Switching an IL6-Type to an IFNγ-Like ResponseChloroquine triggers Epstein-Barr virus replication through phosphorylation of KAP1/TRIM28 in Burkitt lymphoma cellsCross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virusEpstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profileValpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus.Ablation of STAT3 in the B Cell Compartment Restricts Gammaherpesvirus Latency In Vivo.Signal transducer and activator of transcription 3 limits Epstein-Barr virus lytic activation in B lymphocytes.B lymphocytes from patients with a hypomorphic mutation in STAT3 resist Epstein-Barr virus-driven cell proliferationViral microRNAs Target a Gene Network, Inhibit STAT Activation, and Suppress Interferon Responses.Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect.Switching of EBV cycles between latent and lytic states.Regulation of Epstein-Barr virus reactivation from latency.STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle.Cellular immediate-early gene expression occurs kinetically upstream of Epstein-Barr virus bzlf1 and brlf1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line.The replication and transcription activator of murine gammaherpesvirus 68 cooperatively enhances cytokine-activated, STAT3-mediated gene expression.Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns.STAT3 mutations are present in aggressive B-cell lymphomas including a subset of diffuse large B-cell lymphomas with CD30 expressionInterferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction.KRAB-ZFP repressors enforce quiescence of oncogenic human herpesviruses.
P2860
Q26741576-544D4E43-3C0B-4DFA-9717-C346FB74A6A9Q26865827-2DBF3EFD-6A0C-4F22-B18C-15EB77874131Q28551855-FA29CF41-5E7B-4101-8E16-0BA8244D4B04Q30425660-612E1137-16D8-4CBD-9745-1A922CE8A337Q33900360-E934AADE-1C9A-4193-BA4A-4893070F5A21Q34985738-488B1EAF-B86A-46EA-84AF-149D44214D80Q35076733-ED0F265D-4DFB-4A73-BAED-0CED8B5022A5Q35488524-2EB1AB62-E694-4C95-8505-E11B18027EB3Q35641151-C8511685-9292-479E-9105-6699E6B72F2AQ36069672-AC665FAA-CCFF-44DB-AF23-66DF496A5651Q36294186-852269F4-4C28-480D-9583-4A1532FC6F3CQ36346985-698CAC81-029F-44B6-9215-BB17077CF134Q36687528-7C1225E0-2E13-4C93-A8E1-045CB5FC1F92Q36736242-E5A96EEE-AE7E-409D-A283-2702EAC486A4Q37168674-FDA019DB-D24A-418E-95D8-C0DD7580DDB9Q37252690-3B3899F0-49ED-4114-8CFA-4B0E6EEC8C93Q37547616-88ED5561-7AC2-48FB-BE96-0619B983D46EQ37593352-DD64EE7A-9303-4082-B4C4-2FAB2A48DBD8Q37821337-EFCABB93-6B2E-4808-BE40-C40638D51F1AQ38171455-6D4EE6DF-DC28-4582-98F5-8721CABF82C4Q38208532-B4270142-091F-423C-96F3-8EA4211B1350Q38838049-00F8ADC2-8EFD-44CC-8358-297DC7901B95Q39575256-915C259C-50C7-4EB4-AF03-497570FED65BQ39652746-36C34EEA-DACA-4A31-9A4D-3F684F945839Q40077951-58414E13-C764-4133-B45D-687C1EE8DBFBQ40764983-B6CB2ADB-9E39-4F4D-B3F9-8079DCAB0EB4Q41573983-80BFAC7B-B666-4CD9-AAB0-E1D7F0804292Q47550358-07077379-790D-4203-A12D-9A2F2787A7F2Q52563014-736E9EA8-3883-4803-A7BA-9B21209C6482
P2860
Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Upregulation of STAT3 marks Bu ...... e induction by HDAC inhibitors
@en
Upregulation of STAT3 marks Bu ...... induction by HDAC inhibitors.
@nl
type
label
Upregulation of STAT3 marks Bu ...... e induction by HDAC inhibitors
@en
Upregulation of STAT3 marks Bu ...... induction by HDAC inhibitors.
@nl
prefLabel
Upregulation of STAT3 marks Bu ...... e induction by HDAC inhibitors
@en
Upregulation of STAT3 marks Bu ...... induction by HDAC inhibitors.
@nl
P2093
P2860
P356
P1433
P1476
Upregulation of STAT3 marks Bu ...... e induction by HDAC inhibitors
@en
P2093
Ayman El-Guindy
Cynthia Megyola
David Tuck
Derek Daigle
George Miller
Lyn Gradoville
Sumita Bhaduri-McIntosh
P2860
P304
P356
10.1128/JVI.01745-09
P407
P577
2009-11-04T00:00:00Z